Page last updated: 2024-09-05

lasofoxifene and Disease Models, Animal

lasofoxifene has been researched along with Disease Models, Animal in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Chang, YF; Fanning, SW; Green, B; Greene, GL; Greene, ME; Komm, B; Kurleto, JD; Lainé, M; Phung, L	1
Andersson, A; Bernardi, AI; Carlsten, H; Islander, U; Nurkkala-Karlsson, M; Ohlsson, C; Stubelius, A	1
Ke, HZ; Maeda, T; Simmons, H; Thompson, D	1

Reviews

1 review(s) available for lasofoxifene and Disease Models, Animal

Article	Year
[Lasofoxifene, a next generation estrogen receptor modulator: preclinical studies]. Clinical calcium, 2004, Volume: 14, Issue:10 Topics: Animals; Bone Density; Breast Neoplasms; Cholesterol; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Mice; Osteoporosis, Postmenopausal; Pyrrolidines; Rats; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Transcription, Genetic; Uterus	2004

Article

Year

[Lasofoxifene, a next generation estrogen receptor modulator: preclinical studies].

Clinical calcium, 2004, Volume: 14, Issue:10

Topics: Animals; Bone Density; Breast Neoplasms; Cholesterol; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Mice; Osteoporosis, Postmenopausal; Pyrrolidines; Rats; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Transcription, Genetic; Uterus

2004

Other Studies

2 other study(ies) available for lasofoxifene and Disease Models, Animal

Article	Year
Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer. Breast cancer research : BCR, 2021, 05-12, Volume: 23, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Models, Animal; Estrogen Receptor alpha; Female; Fulvestrant; Humans; MCF-7 Cells; Mice; Mutation; Neoplasm Metastasis; Piperazines; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Pyridines; Pyrrolidines; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Treatment Outcome	2021
Selective oestrogen receptor modulators lasofoxifene and bazedoxifene inhibit joint inflammation and osteoporosis in ovariectomised mice with collagen-induced arthritis. Rheumatology (Oxford, England), 2016, Volume: 55, Issue:3 Topics: Animals; Area Under Curve; Arthritis, Experimental; Biomarkers; Collagen; Disease Models, Animal; Female; Flow Cytometry; Humans; Indoles; Interleukin-6; Mice; Mice, Inbred DBA; Osteoarthritis; Osteoporosis, Postmenopausal; Ovariectomy; Pyrrolidines; Random Allocation; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Treatment Outcome	2016

Article

Year

Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer.

Breast cancer research : BCR, 2021, 05-12, Volume: 23, Issue:1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Models, Animal; Estrogen Receptor alpha; Female; Fulvestrant; Humans; MCF-7 Cells; Mice; Mutation; Neoplasm Metastasis; Piperazines; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Pyridines; Pyrrolidines; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Treatment Outcome

2021

Selective oestrogen receptor modulators lasofoxifene and bazedoxifene inhibit joint inflammation and osteoporosis in ovariectomised mice with collagen-induced arthritis.

Rheumatology (Oxford, England), 2016, Volume: 55, Issue:3

Topics: Animals; Area Under Curve; Arthritis, Experimental; Biomarkers; Collagen; Disease Models, Animal; Female; Flow Cytometry; Humans; Indoles; Interleukin-6; Mice; Mice, Inbred DBA; Osteoarthritis; Osteoporosis, Postmenopausal; Ovariectomy; Pyrrolidines; Random Allocation; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Treatment Outcome

2016